LEADER 01387nam2-2200457---4500 001 990000616190203316 005 20070322152945.0 010 $a0-415-14367-5 035 $a0061619 035 $aUSA010061619 035 $a(ALEPH)000061619USA01 035 $a0061619 100 $a20010910d--------km-y0ENGy0103----ba 101 $aeng 102 $aGB 200 1 $a1042-1189$fedited by David C. Douglas and George W. Greenaway$v2 205 $a2 ed. 210 $aLondon$cEyre Methuen 210 $aNew York$cOxford University press$d1979 215 $aXXXI, 1044 p.$cill.$d24 cm 410 $12001 461 $10010061615$12001$aEnglish historical documents 606 $aGran Bretagna$xStoria$xFonti 606 $aGran Bretagna$xStoria$xFonti 676 $a941 702 1$aGREENAWAY,$bGeorge W. 702 1$aDOUGLAS,$bDavid C. 801 0$aIT$bsalbc$gISBD 912 $a990000616190203316 951 $aX.4. 38/2a(941 ENG 2)$b143029 LM$c941 951 $aX.4. 38/2(IL I 13 II)$b19659 L.M.$cIL I 959 $aBK 969 $aUMA 979 $aPATTY$b90$c20010910$lUSA01$h1311 979 $c20020403$lUSA01$h1711 979 $aPATRY$b90$c20040406$lUSA01$h1643 979 $aCOPAT2$b90$c20050516$lUSA01$h1734 979 $aCOPAT4$b90$c20060110$lUSA01$h1643 979 $aCOPAT6$b90$c20070322$lUSA01$h1529 996 $a1042-1189$9957609 997 $aUNISA LEADER 02966nam 2200493 450 001 9910717345303321 005 20221105175745.0 035 $a(CKB)2670000000429459 035 $a(NjHacI)992670000000429459 035 $a(OCoLC)793888628$z(OCoLC)756495878 035 $a(EXLCZ)992670000000429459 100 $a20221105d2011 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 02$aA comparison of joint replacement disparities in VA and non-VA settings $ea systematic review /$fWalid F. Gellad [and three others], editors 210 1$aWashington, DC :$cDepartment of Veterans Affairs, Health Services Research & Development Service,$d2011. 215 $a1 online resource (iv, 55 pages) $cillustrations 225 1 $aEvidence-based Synthesis Program 300 $a"Evidence-based synthesis program." 300 $a"September 2011." 320 $aIncludes bibliographical references. 330 3 $aThe leading cause of disability in the United States is osteoarthritis. There is no known cure. Consequently, osteoarthritis is managed with a variety of treatments to reduce disability, improve function, and alleviate symptoms. When conservative treatments fail, surgical intervention is indicated. The most effective surgical option for moderate to severe osteoarthritis in the knee or hip is total joint replacement (TJR). TJR is often considered appropriate in cases where other non-surgical treatments have not brought adequate relief. TJR in the management of end-stage osteoarthritis is widely utilized and is considered the fastest growing elective surgery in the nation, if not the world. Although TJR is highly successful at treating advanced kip or knee osteoarthritis, there is substantial evidence that disparities exist in TJR utilization in non-VA settings, with racial and ethnic disparities being the most documented. This report compares what is known about disparities in TJR in the VA context with disparities in non-VA settings. 410 0$aEvidence-based synthesis program (Series) 517 $aA comparison of joint replacement disparities in VA and non-VA settings 606 $aArtificial joints 606 $aSurgery$xComplications 607 $aUnited States$2fast 615 0$aArtificial joints. 615 0$aSurgery$xComplications. 676 $a617.580592 700 $aGellad$b Walid F.$01399071 702 $aGellad$b Walid F. 712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service, 712 02$aWest Los Angeles VA Medical Center.$bEvidence-Based Synthesis Program Center. 712 02$aEvidence-based Synthesis Program (U.S.) 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910717345303321 996 $aA comparison of joint replacement disparities in VA and non-VA settings$93463708 997 $aUNINA